SHELL ASSET MANAGEMENT CO - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$393
-10.9%
40,830
-1.5%
0.02%
-5.9%
Q2 2023$441
+0.5%
41,463
-0.6%
0.02%
-5.6%
Q1 2023$439
-15.3%
41,697
-0.3%
0.02%
-21.7%
Q4 2022$518
-99.9%
41,841
-17.4%
0.02%
+15.0%
Q3 2022$525,000
-28.8%
50,679
-20.8%
0.02%
-9.1%
Q2 2022$737,000
-8.2%
63,959
+0.2%
0.02%
+15.8%
Q1 2022$803,000
-6.1%
63,850
-12.9%
0.02%
+5.6%
Q4 2021$855,000
-10.3%
73,295
+0.5%
0.02%
-14.3%
Q3 2021$953,000
-2.7%
72,957
-4.1%
0.02%
+10.5%
Q2 2021$979,000
+60.5%
76,087
+39.5%
0.02%
+58.3%
Q1 2021$610,000
+139.2%
54,539
+143.2%
0.01%
+140.0%
Q4 2020$255,000
+26.2%
22,4270.0%0.01%0.0%
Q3 2020$202,000
-12.6%
22,4270.0%0.01%
-16.7%
Q2 2020$231,000
+102.6%
22,427
+99.0%
0.01%
+100.0%
Q1 2020$114,000
-25.0%
11,270
-1.5%
0.00%0.0%
Q4 2019$152,000
+50.5%
11,442
-2.4%
0.00%
+50.0%
Q3 2019$101,000
-21.7%
11,723
-0.9%
0.00%
-33.3%
Q2 2019$129,000
-21.3%
11,824
-2.2%
0.00%
-25.0%
Q1 2019$164,000
+31.2%
12,0940.0%0.00%
+33.3%
Q4 2018$125,000
-48.3%
12,094
-7.6%
0.00%
-40.0%
Q3 2018$242,000
-3.2%
13,0940.0%0.01%0.0%
Q2 2018$250,000
+17.4%
13,094
-5.3%
0.01%
+25.0%
Q1 2018$213,000
+2.9%
13,8330.0%0.00%0.0%
Q4 2017$207,00013,8330.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$172,422,80022.05%
13D Management LLC 533,562$5,613,0732.85%
Quantedge Capital Pte Ltd 541,200$5,693,4242.22%
Price Jennifer C. 520,000$5,470,4001.74%
Tamarack Advisers, LP 210,000$2,209,2000.81%
Intrinsic Value Partners, LLC 51,605$542,8850.73%
Brown Capital Management 3,933,933$41,384,9750.62%
Old West Investment Management, LLC 75,219$791,3030.43%
EMC Capital Management 43,315$4560.38%
Hillsdale Investment Management Inc. 420,617$4,424,8910.38%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders